These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35791078)

  • 21. The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice.
    Garrido-Mesa N; Utrilla P; Comalada M; Zorrilla P; Garrido-Mesa J; Zarzuelo A; Rodríguez-Cabezas ME; Gálvez J
    Biochem Pharmacol; 2011 Dec; 82(12):1891-900. PubMed ID: 21930116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis.
    Jawhara S; Poulain D
    Med Mycol; 2007 Dec; 45(8):691-700. PubMed ID: 17885943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel probiotic yeast from Miso promotes regulatory dendritic cell IL-10 production and attenuates DSS-induced colitis in mice.
    Okada Y; Tsuzuki Y; Sugihara N; Nishii S; Shibuya N; Mizoguchi A; Itoh S; Tanemoto R; Inaba K; Hanawa Y; Horiuchi K; Wada A; Higashiyama M; Watanabe C; Kurihara C; Komoto S; Tomita K; Miura S; Hokari R
    J Gastroenterol; 2021 Sep; 56(9):829-842. PubMed ID: 34213612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis.
    Heavey MK; Hazelton A; Wang Y; Garner M; Anselmo AC; Arthur JC; Nguyen J
    Nat Commun; 2024 May; 15(1):3784. PubMed ID: 38710716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice.
    Dong F; Xiao F; Li X; Li Y; Wang X; Yu G; Zhang T; Wang Y
    J Transl Med; 2022 Jan; 20(1):33. PubMed ID: 35033121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific probiotic dietary supplementation leads to different effects during remission and relapse in murine chronic colitis.
    Zheng B; van Bergenhenegouwen J; van de Kant HJ; Folkerts G; Garssen J; Vos AP; Morgan ME; Kraneveld AD
    Benef Microbes; 2016; 7(2):205-13. PubMed ID: 26645352
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Yu P; Ke C; Guo J; Zhang X; Li B
    Front Immunol; 2020; 11():575173. PubMed ID: 33123156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulsatilla decoction improves DSS-induced colitis via modulation of fecal-bacteria-related short-chain fatty acids and intestinal barrier integrity.
    Niu C; Hu XL; Yuan ZW; Xiao Y; Ji P; Wei YM; Hua YL
    J Ethnopharmacol; 2023 Jan; 300():115741. PubMed ID: 36162543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice.
    Gaudier E; Michel C; Segain JP; Cherbut C; Hoebler C
    J Nutr; 2005 Dec; 135(12):2753-61. PubMed ID: 16317116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of probiotics with different functions alleviate DSS-induced colitis by regulating intestinal microbiota, IL-10, and barrier function.
    Wang Y; Xie Q; Zhang Y; Ma W; Ning K; Xiang JY; Cui J; Xiang H
    Appl Microbiol Biotechnol; 2020 Jan; 104(1):335-349. PubMed ID: 31758237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grape seed proanthocyanidin extract ameliorates dextran sulfate sodium-induced colitis through intestinal barrier improvement, oxidative stress reduction, and inflammatory cytokines and gut microbiota modulation.
    Sheng K; Zhang G; Sun M; He S; Kong X; Wang J; Zhu F; Zha X; Wang Y
    Food Funct; 2020 Sep; 11(9):7817-7829. PubMed ID: 32808642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease.
    Tiago FC; Porto BA; Ribeiro NS; Moreira LM; Arantes RM; Vieira AT; Teixeira MM; Generoso SV; Nascimento VN; Martins FS; Nicoli JR
    Benef Microbes; 2015; 6(6):807-15. PubMed ID: 26322540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semi-Rational Screening of Probiotics from the Fecal Flora of Healthy Adults against DSS-Induced Colitis Mice by Enhancing Anti-Inflammatory Activity and Modulating the Gut Microbiota.
    Wang W; Xing W; Wei S; Gao Q; Wei X; Shi L; Kong Y; Su Z
    J Microbiol Biotechnol; 2019 Sep; 29(9):1478-1487. PubMed ID: 30270604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presume Why Probiotics May Not Provide Protection in Inflammatory Bowel Disease through an Azoxymethane and Dextran Sodium Sulfate Murine Model.
    Hu ML; Lian WS; Wang FS; Yang CH; Huang WT; Yang JW; Chen IY; Yang MY
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077084
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Meng Y; Zhang L; Li P; Yu J; Mu G; Li X; Tuo Y
    Foods; 2022 May; 11(10):. PubMed ID: 35627006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Probiotics on Colitis-Induced Exacerbation of Alzheimer's Disease in
    Sahu B; Johnson LM; Sohrabi M; Usatii AA; Craig RMJ; Kaelberer JB; Chandrasekaran SP; Kaur H; Nookala S; Combs CK
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of selected Lactobacillus strains on dextran sulfate sodium-induced mouse colitis model.
    Hasannejad-Bibalan M; Mojtahedi A; Eshaghi M; Rohani M; Pourshafie MR; Talebi M
    Acta Microbiol Immunol Hung; 2020 Jun; 67(2):138-142. PubMed ID: 32554841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional
    Panpetch W; Hiengrach P; Nilgate S; Tumwasorn S; Somboonna N; Wilantho A; Chatthanathon P; Prueksapanich P; Leelahavanichkul A
    Gut Microbes; 2020 May; 11(3):465-480. PubMed ID: 31530137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.
    Capece A; Romaniello R; Pietrafesa A; Siesto G; Pietrafesa R; Zambuto M; Romano P
    Int J Food Microbiol; 2018 Nov; 284():22-30. PubMed ID: 29990636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
    Brun P; Scarpa M; Marchiori C; Sarasin G; Caputi V; Porzionato A; Giron MC; Palù G; Castagliuolo I
    PLoS One; 2017; 12(7):e0181863. PubMed ID: 28732069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.